Nova Laboratories - Articles and news items

Nova lab

Nova Laboratories secures FDA approval for Xaluprine

Industry news / 1 May 2014 / Nova Laboratories

UK pharmaceutical firm Nova Laboratories has secured U.S Food and Drug Administration approval for its acute lymphoblastic leukaemia (ALL) product Xaluprine…

Nova lab

Nova Laboratories announces FDA filing of New Drug Application for the treatment of childhood acute lymphoblastic leukemia

Industry news / 4 December 2013 / Nova Laboratories

The product has been granted orphan drug designation by the FDA, a status given to a product intended for the treatment of a rare disease or condition…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...